Early echocardiographic results of patients undergoing transcatheter aortic valve replacement (TAVR) with the new-generation SAPIEN 3 Ultra Resilia (S3UR) balloon-expandable transcatheter heart valve (THV) show superior hemodynamic performance compared to the SAPIEN 3 (S3) device.